Mehdi Sanati

Employment

• University Medical Center Utrecht Postdoctoral researcher
  2024 - Present
• Birjand University of Medical Sciences Faculty member
  2020 - 2024

Education

• Tehran University of Medical Sciences PhD Candidate
  2013 - 2019

Projects & Funding

Projects & funding information is unavailable.

Publications (40)

• Exploring bone-tumor interactions through 3D in vitro models: Implications for primary and metastatic cancers
  Journal of Bone Oncology 2025 DOI: 10.1016/j.jbo.2025.100698
  +Save
• Repurposing ivermectin: a new hope for glioblastoma multiforme?
  Medicinal Chemistry Research 2025 DOI: 10.1007/s00044-025-03435-z
  +Save
• A novel approach to glioblastoma multiforme treatment using modulation of key pathways by naturally occurring small molecules
  Inflammopharmacology 2025 DOI: 10.1007/s10787-025-01666-5
  +Save
• Osteoimmunomodulation by bone implant materials: harnessing physicochemical properties and chemical composition
  Biomaterials Science 2025 DOI: 10.1039/D5BM00357A
  +Save
• Bioengineered Nanomaterials for siRNA Therapy of Chemoresistant Cancers
  ACS Nano 2024 DOI: 10.1021/acsnano.4c11259
  +Save
• Carbohydrates and neurotrophic factors: A promising partnership for spinal cord injury rehabilitation
  Biomaterials Advances 2024 DOI: 10.1016/j.bioadv.2024.214054
  +Save
• Unveiling the theranostic potential of SPIONs in Alzheimer's disease management
  Journal of Psychiatric Research 2024 DOI: 10.1016/j.jpsychires.2024.09.022
  +Save
• Impact of Rapamycin on Longevity: Updated Insights
  Archives of Medical Science 2024 DOI: 10.5114/aoms/191565
  +Save
• Harnessing the capacity of phytochemicals to enhance immune checkpoint inhibitor therapy of cancers: A focus on brain malignancies
  Cancer Letters 2024 DOI: 10.1016/j.canlet.2024.216955
  +Save
• Liposome-integrated hydrogel hybrids: Promising platforms for cancer therapy and tissue regeneration
  Journal of Controlled Release 2024 DOI: 10.1016/j.jconrel.2024.03.008
  +Save
• Curcumin-drug conjugate-based drug delivery as cancer therapeutics
  Curcumin-Based Nanomedicines as Cancer Therapeutics 2024 DOI: 10.1016/b978-0-443-15412-6.00016-7
  +Save
• Nanohybrid drug delivery approach as a novel opportunity for curcumin delivery in cancer
  Curcumin-Based Nanomedicines as Cancer Therapeutics 2024 DOI: 10.1016/b978-0-443-15412-6.00019-2
  +Save
• Advances in liposome-based delivery of RNA therapeutics for cancer treatment
  Progress in Molecular Biology and Translational Science 2024 DOI: 10.1016/bs.pmbts.2023.12.010
  +Save
• Application of RNA-based therapeutics in glioma: A review
  Progress in Molecular Biology and Translational Science 2023 DOI: 10.1016/bs.pmbts.2023.12.001
  +Save
• Recent advances in codelivery of curcumin and siRNA as anticancer therapeutics
  European Polymer Journal 2023 DOI: 10.1016/j.eurpolymj.2023.112444
  +Save
• Recent Advances in Curcumin-Based Combination Nanomedicines for Cancer Therapy
  Amir R. Afshari, Mehdi Sanati, Prashant Kesharwani +1 more
  Journal of Functional Biomaterials 2023 DOI: 10.3390/jfb14080408
  +Save
• Aptamers against cancer drug resistance: Small fighters switching tactics in the face of defeat
  Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease 2023 DOI: 10.1016/j.bbadis.2023.166720
  +Save
• Modulation of the ubiquitin‐proteasome system by phytochemicals: Therapeutic implications in malignancies with an emphasis on brain tumors
  BioFactors 2023 DOI: 10.1002/biof.1958
  +Save
• RGD-engineered nanoparticles as an innovative drug delivery system in cancer therapy
  Journal of Drug Delivery Science and Technology 2023 DOI: 10.1016/j.jddst.2023.104562
  +Save
• The Potential Therapeutic Impact of Metformin in Glioblastoma Multiforme
  Current Medicinal Chemistry 2023 DOI: 10.2174/0929867329666220707103525
  +Save